Trigger point injection treatment with the 5-HT3 receptor antagonist tropisetron in patients with late whiplash-associated disorder. First results of a multiple case study.
Preliminary results of an ongoing study on the effectiveness of trigger point injections with tropisetron in 20 patients with late whiplash-associated disorder are presented. The study demonstrated more than 50% pain relief for more than 2 weeks in 52% of the 73 treatment sessions. The duration of effectiveness of the injections showed great intraindividual and interindividual variation.
Ettlin
Th
T
Rheinfelden Rehabilitation Center, Rheinfelden, Switzerland. th.ettlin@rkr.ch
D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D007267:Injections; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists / Q000008:administration & dosage*; D000077526:Tropisetron; D014911:Whiplash Injuries / Q000150:complications*
D007211:Indoles; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists; D000077526:Tropisetron